XPO1/CRM1-selective inhibitors of nuclear export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa). (Q38950408)
Jump to navigation
Jump to search
scientific article published on 5 October 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | XPO1/CRM1-selective inhibitors of nuclear export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa). |
scientific article published on 5 October 2014 |
Statements
1 reference
XPO1/CRM1-selective inhibitors of nuclear export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa). (English)
1 reference
1 reference
Monica Tortoreto
1 reference
Alessandro Addis
1 reference
Yosef Landesman
1 reference
Dilara McCauley
1 reference
Michael Kauffman
1 reference
Sharon Shacham
1 reference
Claudio Festuccia
1 reference
5 October 2014
1 reference
1 reference
46
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference